您的位置: 首页 > 2024年8月 第55卷 第8期 > 文字全文
2023年7月 第38卷 第7期11
目录

内托生肌法治疗肉芽肿性乳腺炎溃后期的临床疗效

Clinical efficacy of endotropic muscle-generating therapy in treating late-stage ulcerative granulomatous mastitis

来源期刊: 广州医药 | 888-894 发布时间:2024-09-24 收稿时间:2025/11/17 15:48:25 阅读量:90
作者:
关键词:
肉芽肿性乳腺炎溃后期内托生肌法
granulomatous mastitislate stage of ulcerationendotropic muscle-generating method
DOI:
10.3969/j.issn.1000-8535.2024.08.010
收稿时间:
2024-01-08 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 研究内托生肌法治疗肉芽肿性乳腺炎溃后期的临床疗效。方法 63例符合肉芽肿性乳腺炎溃后期的患者,分为西药组31例和中药组32例。西医药组予常规激素、抗生素等治疗,中药组予内托生肌法,加减组方,两组治疗时间为6个月。比较两组患者的疾病转归、乳房外形评价、临床症状观察评分等指标。结果 中药组6个月治愈率高于西药组,中药组临床治愈18例(56.2%)、痊愈11例(34.4%),相较于西药组临床治愈11例(35.5%)和痊愈9例(29%);治疗后中药组乳房外形评价优于西药组,中药组临床症状评分较低,组间比较差异具有统计学意义。两组患者治疗前后免疫球蛋白IgA、IgG、IgM水平比较差异均未见统计学意义。中药组相较于西药组不良反应更少,患者依从性更高。结论 内托生肌法治疗肉芽肿性乳腺炎溃后期能促进肉芽肿创面愈合,加快肉芽组织新生,改善破溃流脓症状以及在恢复乳房外观方面具有明显的优势。
Objective To study the clinical efficacy of endotropic muscle-generating therapy in treating late-stage ulcerative granulomatous mastitis.Methods Sixty-three eligible patients were included in the western medicine group(31 cases)and the traditional Chinese medicine group(32 cases).The western medicine group received conventional hormones and antibiotics,while the traditional Chinese medicine group received the endotropic muscle-generating method with adjustments.The treatment duration for both groups was six months.Disease regression,breast shape evaluation,clinical symptom observation scores,and other relevant indices of both groups were compared.Results The study found that the six-month cure rate in the traditional Chinese medicine group(56.2% clinically cured,34.4% cured)exceeded that of the western medicine group(35.5% clinically cured,29% cured).Breast appearance evaluation in the traditional Chinese medicine group significantly better that of the western medicine group post-treatment,and clinical symptom scores were lower,demonstrating a statistically significant difference.Before and after treatment,there was no significant difference in the levels of immunoglobulins A,G,and M observed between the two groups.The traditional Chinese medicine group exhibited fewer side effects and higher patient compliance compared to the western medicine group.Conclusions The endotropic muscle-generating method,when employed to treat granulomatous mastitis in the late ulcerative stage,proves effective in promoting granulomatous wound healing,accelerating the generation of new granulation tissue,and improving ulceration and pus flow symptoms.Additionally,it contributes to the restoration of breast appearance.
1、 陶颖娜,万华.哺乳期乳腺炎免疫发病机制的研究进展[J].医学综述,2017,23(12):2333-2338. 陶颖娜,万华.哺乳期乳腺炎免疫发病机制的研究进展[J].医学综述,2017,23(12):2333-2338.
2、 夏亚茹,陈红风,叶媚娜,等.非哺乳期乳腺炎患者外周血T淋巴细胞、免疫球蛋白及补体水平的变化[J].中华乳腺病杂志(电子版),2012,6(5):504-514. 夏亚茹,陈红风,叶媚娜,等.非哺乳期乳腺炎患者外周血T淋巴细胞、免疫球蛋白及补体水平的变化[J].中华乳腺病杂志(电子版),2012,6(5):504-514.
3、 蔡明珠. 内托生肌散促进糖尿病合并肛周脓肿术后创面愈合的临床研究[J].糖尿病新世界,2019,22(3):91-92. 蔡明珠. 内托生肌散促进糖尿病合并肛周脓肿术后创面愈合的临床研究[J].糖尿病新世界,2019,22(3):91-92.
4、 梁秋萍. 加减内托生肌散促进肛瘘术后创面愈合的临床观察[D].福州:福建中医药大学,2014. 梁秋萍. 加减内托生肌散促进肛瘘术后创面愈合的临床观察[D].福州:福建中医药大学,2014.
5、 唐甜. 拔毒生肌散治疗非哺乳期乳腺炎窦道脓腐的临床研究[D].南京:南京中医药大学,2019. 唐甜. 拔毒生肌散治疗非哺乳期乳腺炎窦道脓腐的临床研究[D].南京:南京中医药大学,2019.
6、 关青青. 祛腐生肌法治疗非哺乳期乳腺炎溃后期疗效观察[D].北京:北京中医药大学,2018. 关青青. 祛腐生肌法治疗非哺乳期乳腺炎溃后期疗效观察[D].北京:北京中医药大学,2018.
7、 朱华宇,司徒红林,关若丹,等.林毅运用中医特色疗法治疗肉芽肿性乳腺炎经验举要[J].新中医,2013,45(6):189-191. 朱华宇,司徒红林,关若丹,等.林毅运用中医特色疗法治疗肉芽肿性乳腺炎经验举要[J].新中医,2013,45(6):189-191.
8、 AZZAM M I,ALNAIMAT F,AL-NAZER M W,et al.Idiopathic granulomatous mastitis:Clinical,histopathological,and radiological characteristics and management approaches[J].Rheumatol Int,2023,43(10):1859-1869. AZZAM M I,ALNAIMAT F,AL-NAZER M W,et al.Idiopathic granulomatous mastitis:Clinical,histopathological,and radiological characteristics and management approaches[J].Rheumatol Int,2023,43(10):1859-1869.
9、 FATTAHI A S,AMINI G,SAJEDI F,et al.Factors affecting recurrence of idiopathic granulomatous mastitis:A systematic review[J].Breast J,2023(2023):9947797. FATTAHI A S,AMINI G,SAJEDI F,et al.Factors affecting recurrence of idiopathic granulomatous mastitis:A systematic review[J].Breast J,2023(2023):9947797.
10、 DILAVERI C,DEGNIM A,LEE C,et al.Idiopathic granulomatous mastitis[J].Breast J,2024(2024):6693720. DILAVERI C,DEGNIM A,LEE C,et al.Idiopathic granulomatous mastitis[J].Breast J,2024(2024):6693720.
11、 YUAN Q Q,XIAO S Y,FAROUK O,et al.Management of granulomatous lobular mastitis:An international multidisciplinary consensus(2021 edition)[J].Mil Med Res,2022,9(1):20. YUAN Q Q,XIAO S Y,FAROUK O,et al.Management of granulomatous lobular mastitis:An international multidisciplinary consensus(2021 edition)[J].Mil Med Res,2022,9(1):20.
12、 ZENG Y,ZHANG D,ZHAO W,et al.Predisposing factors for granulomatous lobular mastitis:A case-control study[J].Int J Womens Health,2023(15):1063-1075. ZENG Y,ZHANG D,ZHAO W,et al.Predisposing factors for granulomatous lobular mastitis:A case-control study[J].Int J Womens Health,2023(15):1063-1075.
13、 YAGHAN R,HAMOURI S,AYOUB N M,et al.A proposal of a clinically based classification for idiopathic granulomatous mastitis[J].Asian Pac J Cancer Prev,2019,20(3):929-934. YAGHAN R,HAMOURI S,AYOUB N M,et al.A proposal of a clinically based classification for idiopathic granulomatous mastitis[J].Asian Pac J Cancer Prev,2019,20(3):929-934.
14、 STEUER A B,STERN M J,COBOS G,et al.Clinical characteristics and medical management of idiopathic granulomatous mastitis[J].JAMA Dermatol,2020,156(4):460-464. STEUER A B,STERN M J,COBOS G,et al.Clinical characteristics and medical management of idiopathic granulomatous mastitis[J].JAMA Dermatol,2020,156(4):460-464.
15、 DAVIS J,COCCO D,MATZ S,et al.Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis[J].Surgery,2019,166(6):1176-1180. DAVIS J,COCCO D,MATZ S,et al.Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis[J].Surgery,2019,166(6):1176-1180.
16、 PLUGUEZ-TURULL C W,NANYES J E,QUINTERO C J,et al.Idiopathic granulomatous mastitis:Manifestations at multimodality imaging and pitfalls[J].Radiographics,2018,38(2):330-356. PLUGUEZ-TURULL C W,NANYES J E,QUINTERO C J,et al.Idiopathic granulomatous mastitis:Manifestations at multimodality imaging and pitfalls[J].Radiographics,2018,38(2):330-356.
17、 GOING J J,ANDERSON T J,WILKINSON S,et al.Granulomatous lobular mastitis[J].J Clin Pathol,1987,40(5):535-540. GOING J J,ANDERSON T J,WILKINSON S,et al.Granulomatous lobular mastitis[J].J Clin Pathol,1987,40(5):535-540.
18、 MILLER F,SEIDMAN I,SMITH C A.Granulomatous mastitis[J].N Y State J Med,1971,71(8):2194-2195. MILLER F,SEIDMAN I,SMITH C A.Granulomatous mastitis[J].N Y State J Med,1971,71(8):2194-2195.
19、 覃勇娟,张海添.中医药治疗非哺乳期乳腺炎[J].光明中医,2024,39(12):2371-2374. 覃勇娟,张海添.中医药治疗非哺乳期乳腺炎[J].光明中医,2024,39(12):2371-2374.
20、 韩旭,张杰,李银燕.加减透脓散配合乳痈散外敷治疗肉芽肿性小叶性乳腺炎64例[J].辽宁中医杂志,2022,49(4):75-79. 韩旭,张杰,李银燕.加减透脓散配合乳痈散外敷治疗肉芽肿性小叶性乳腺炎64例[J].辽宁中医杂志,2022,49(4):75-79.
21、 王颀,杨剑敏,于海静.肉芽肿性乳腺炎的诊断与处理原则[J].中国实用外科杂志,2016,36(7):734-738. 王颀,杨剑敏,于海静.肉芽肿性乳腺炎的诊断与处理原则[J].中国实用外科杂志,2016,36(7):734-738.
22、 刘晓雁,陈前军.肉芽肿性小叶性乳腺炎中医诊疗专家共识(2021版)[J].中国中西医结合外科杂志,2022,28(5):597-602. 刘晓雁,陈前军.肉芽肿性小叶性乳腺炎中医诊疗专家共识(2021版)[J].中国中西医结合外科杂志,2022,28(5):597-602.
23、 BARRETO D S,SEDGWICK E L,NAGI C S,et al.Granulomatous mastitis:Etiology,imaging,pathology,treatment,and clinical findings[J].Breast Cancer Res Treat,2018,171(3):527-534. BARRETO D S,SEDGWICK E L,NAGI C S,et al.Granulomatous mastitis:Etiology,imaging,pathology,treatment,and clinical findings[J].Breast Cancer Res Treat,2018,171(3):527-534.
24、 于海静,王颀,何舟,等.218例肉芽肿性乳腺炎的临床病理特征及分类诊疗[J].中华乳腺病杂志(电子版),2018,12(2):84-92. 于海静,王颀,何舟,等.218例肉芽肿性乳腺炎的临床病理特征及分类诊疗[J].中华乳腺病杂志(电子版),2018,12(2):84-92.
25、 王颀. 应重视非哺乳期乳腺炎的诊治和研究[J].中华乳腺病杂志(电子版),2013,7(3):1-3. 王颀. 应重视非哺乳期乳腺炎的诊治和研究[J].中华乳腺病杂志(电子版),2013,7(3):1-3.
26、 LLANCARI P A,ORTIZ A,BECERRA J,et al.Treatment and management experience of idiopathic granulomatous mastitis in a low-income country[J].Rev Bras Ginecol Obstet,2023,45(6):319-324. LLANCARI P A,ORTIZ A,BECERRA J,et al.Treatment and management experience of idiopathic granulomatous mastitis in a low-income country[J].Rev Bras Ginecol Obstet,2023,45(6):319-324.
27、 RAMADAN R,KORYEM I M,FAYED H.Idiopathic granulomatous mastitis:Risk factors and management[J].Breast Dis,2022,41(1):413-420. RAMADAN R,KORYEM I M,FAYED H.Idiopathic granulomatous mastitis:Risk factors and management[J].Breast Dis,2022,41(1):413-420.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录